About Robert Gardner

Robert is Vice President, Insights Business Development at Inspire. With a background in healthcare market research and social listening, Robert has helped clinical and commercial teams across pharma unlock the power of structured and unstructured data through quantitative and qualitative patient insights. Robert is a graduate of Rutgers University, where he focused his studies on finance and economics.
Vice President, Insights Business Development

Patients Are The Best Resource For Defining Study Endpoints

Patients Are The Best Resource For Defining Study Endpoints By Robert Gardner In September, the World Orphan Drug Congress USA Fall Webinar series opened with a program called: “Understanding the Novel Challenges in Rare Disease Development: Perspectives From Experts.” They took an audience poll, asking attendees to identify their “biggest challenge in rare disease studies” from five choices, including competition for patients; lack of understanding of disease progression; development of appropriate endpoints; lack of data; and global regulatory pathways. Almost half the respondents -- 46% -- chose “development of appropriate endpoints” as the biggest challenge in rare [...]

Where Can I Get This ‘Real World Data’ You Speak Of?

Where Can I Get This ‘Real World Data’ You Speak Of? By Robert Gardner How far has the importance of Real World Evidence advanced as part of treatment development? When the attendees of a recent eyeforpharma webinar were asked, “Are you, or will you soon be using RWE for enabling new types of value or outcomes-based assessment within your own firm?” 35 percent responded that they already consider RWE “a universal and necessary standard,” with another 26 percent saying RWE is or will be used as evidence in developing “specialty and high-priced treatments.” A “universal and [...]

Inspire’s new “Discover” solution delivers unprecedented, real-world patient insights

Inspire’s new “Discover” solution delivers unprecedented, real-world patient insights By Robert Gardner Life science companies can gain a deeper understanding of the patient experience and, in the process, empower their decision-making, through the analysis of unbiased and uncensored discussions occurring publicly on social media and particularly on Inspire. Inspire has something that no other healthcare social network has - Inspire’s proprietary, longitudinal data. Our new solution, Inspire Insights: Discover, is a social listening suite of products combining the real world patient-engagement of Inspire’s patient support communities with other open-source, publicly available, online social media content from [...]